Physician profile
Gary P Barth
NPI 1992783237
$783.07
in general payments reported to CMS, 2019-2025
9 companies · $167 in 2025
The $167 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $136 · 2021: $71.76 · 2022: $67.31 · 2023: $241 · 2024: $99.64 · 2025: $167.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $482 · Honoraria: $25.59.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $481.97 |
| Honoraria | $25.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rxsight INC | $291.67 | 2022-2024 | Rxsight Injector Handpiece, Rxsight Injector Cartridge, Rxsight Light Delivery Device (Ldd) |
| Lensar, INC. | $136.44 | 2019 | |
| Apellis Pharmaceuticals, INC. | $122.70 | 2025 | Syfovre |
| Johnson & Johnson Surgical Vision, INC. | $66.54 | 2022-2023 | Tecnis Iol, Tecnis Iol |
| Carl Zeiss Meditec USA, INC. | $49.68 | 2022-2024 | Cirrus Hd-Oct, Visumax, Veracity Surgical |
| Beaver-Visitec International, INC. | $44.30 | 2021-2025 | |
| Lombart Brothers, INC. | $34.50 | 2021 | |
| Rayner Intraocular Lenses Limited | $22.50 | 2025 | Rayner Cataract Set 1, Rayone Emv, Rayone Aspheric |
| Alcon Vision LLC | $14.74 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gary Barth listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.